WuXi AppTec Co. posted better-than-expected third-quarter revenue despite concerns over a US bill seeking to block the ...

SouthernSun Asset Management, LLC, an investment management firm, released its “SouthernSun Small Cap Strategy” third quarter ...

William Blair analyst Sami Corwin has maintained their bullish stance on TNYA stock, giving a Buy rating yesterday. Sami Corwin has given his ...

Analyst Michael Petusky of Barrington maintained a Buy rating on US Physical Therapy (USPH – Research Report), retaining the price target ...

U.S. drugmaker AbbVie said on Monday it will buy Aliada Therapeutics for $1.4 billion in cash, betting on an experimental ...

These preclinical findings could lead ... Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding ...

Nkarta faces competition from FATE's FT522, a CAR-NK cell therapy that might be used with reduced or no conditioning ...

Compass Pathways is advancing pivotal trials to test psilocybin's impact on treatment-resistant depression. See why I rate ...

Autolus Therapeutics’ (NASDAQ:AUTL) obe-cel has the potential to become a best-in-class cell therapy for the treatment of cancers. Industry analysts have a consensus Buy rating on the stock ...

U.S. Physical Therapy, Inc. (“USPH”) (NYSE ... USPH also has an industrial injury prevention business which provides onsite services for clients’ employees ...

Good morning and welcome to Ocugen's third quarter 2024 financial results and business update. [Operator instructions ... On rare occasions, our expert team of analysts issues a “Double Down” stock ...

This growth will likely be driven by a less restrictive monetary policy and ongoing improvements in real wages, which could boost consumption and business investment. However, in the longer term ...